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 CASE REPORT Open Access
Atypical blood glucose response to
continuous and interval exercise in a
person with type 1 diabetes: a case report
Othmar Moser1,2,3,4* , Gerhard Tschakert1, Alexander Mueller1,5, Werner Groeschl1, Thomas R. Pieber2,
Gerd Koehler2, Max L. Eckstein3,4, Richard M. Bracken3,4 and Peter Hofmann1
Abstract
Background: Therapy must be adapted for people with type 1 diabetes to avoid exercise-induced hypoglycemia
caused by increased exercise-related glucose uptake into muscles. Therefore, to avoid hypoglycemia, the
preexercise short-acting insulin dose must be reduced for safety reasons. We report a case of a man with long-
lasting type 1 diabetes in whom no blood glucose decrease during different types of exercise with varying exercise
intensities and modes was found, despite physiological hormone responses.
Case presentation: A Caucasian man diagnosed with type 1 diabetes for 24 years performed three different continuous
high-intensity interval cycle ergometer exercises as part of a clinical trial (ClinicalTrials.gov identifier NCT02075567).
Intensities for both modes of exercises were set at 5% below and 5% above the first lactate turn point and 5% below the
second lactate turn point. Short-acting insulin doses were reduced by 25%, 50%, and 75%, respectively. Measurements
taken included blood glucose, blood lactate, gas exchange, heart rate, adrenaline, noradrenaline, cortisol, glucagon, and
insulin-like growth factor-1. Unexpectedly, no significant blood glucose decreases were observed during all exercise
sessions (start versus end, 12.97 ± 2.12 versus 12.61 ± 2.66 mmol L−1, p = 0.259). All hormones showed the expected
response, dependent on the different intensities and modes of exercises.
Conclusions: People with type 1 diabetes typically experience a decrease in blood glucose levels, particularly during low-
and moderate-intensity exercises. In our patient, we clearly found no decline in blood glucose, despite a normal hormone
response and no history of any insulin insensitivity. This report indicates that there might be patients for whom the
recommended preexercise therapy adaptation to avoid exercise-induced hypoglycemia needs to be questioned because
this could increase the risk of severe hyperglycemia and ketosis.
Keywords: Type 1 diabetes, Exercise, Blood glucose, Hormones
Background
A precise match in the rates of glucose appearance (Ra)
and disappearance (Rd) ensures euglycemia during phys-
ical activity and exercise in healthy individuals. In people
with type 1 diabetes, hormone responses and the accom-
panying effects on blood glucose levels are impaired
because of autoimmune destruction of insulin-producing
β-cells, resulting in a mismatch in Ra and Rd. Shetty et al.
[1] found an inverted U-shaped relationship between exer-
cise intensity and glucose requirement investigated via
glucose infusion rate in a euglycemic clamp. In line with
valuable reviews [2, 3], it is suggested to adapt therapy to
avoid exercise-induced hypoglycemia. Three possible
strategies have been identified to reduce the risk of
exercise-induced hypoglycemia: (1) insulin reduction [4],
(2) supplementation with extra carbohydrates [5], and (3)
the combination of insulin reduction and carbohydrate
ingestion [6]. To the best of our knowledge, stable
blood glucose levels during different intensities and
types of exercise, accompanied by physiological
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hormone responses, in people with type 1 diabetes
have not been reported in any studies.
Case presentation
Our patient was a Caucasian man with long-lasting type
1 diabetes (age 31 years, body mass index 23.8 kg m−2,
C-peptide 0.00 nmol L−1, glycosylated hemoglobin A1c
60 mmol mol−1 [7.6%], diabetes duration 24 years) was
switched to insulin degludec (Tresiba®; Novo Nordisk,
Bagsvaerd, Denmark) for study purposes (once-daily in-
jection, 19 U/day in the evening) [4]. A run-in period of
4 weeks ensured optimal ultra-long-acting insulin ther-
apy. Before adaptation to insulin degludec, the patient
was receiving insulin glargine (Lantus®; Sanofi-Aventis,
Paris, France) as a basal routine (twice-daily injections, 5
U in the morning and 18 U in the evening). The patient
was treated with insulin lispro (Humalog®; Eli Lilly
Australia, West Ryde, Australia) with a carbohydrate fac-
tor of 1 U of insulin lispro per 12 g of carbohydrates; a
correction factor of 1 U of insulin lispro lowers blood
glucose by 2.8 mmol L−1.
The patient showed normal signs for the respiratory,
cardiovascular, and gastrointestinal systems. The results
of skin and lymph node palpation examinations were
normal. No signs of neuropathy were found, and the pa-
tient was free of any comorbidities. The results of urine
microalbumin and retinopathy screening were negative.
The patient’s blood pressure after 5 minutes of resting
was 118 mmHg (systolic)/74 mmHg (diastolic) at the
screening visit. Laboratory assessment revealed normal
results: C-reactive protein 5.71 nmol L−1, aspartate ami-
notransferase 0.4 μkat L−1, alanine aminotransferase 0.28
μkat L−1, alkaline phosphatase 0.72 μkat L−1, γ-
glutamyltransferase 0.25 μkat L−1, albumin 61.4%,
natrium 137 mmol L−1, potassium 4.4 mmol L−1, magne-
sium 0.77 mmol L−1, urea 12.14 mmol L−1, creatinine
83.88 μmol L−1, glomerular filtration rate 1.5 ml s−1 m−2,
and uric acid 392.6 μmol L−1.
Exercise testing
The patient performed a maximum incremental exercise
test on a cycle ergometer to determine exercise inten-
sities for the continuous and interval exercise tests. The
first lactate turn point (LTP1) and the second lactate
turn point (LTP2) were identified by a linear regression
break point analysis for the lactate concentration to
power output curve. Low (L), moderate (M), and heavy
(H) workload intensities for the continuous and interval
exercises were set at 5% of the maximum power output
(Pmax) from the incremental exercise test below (L) and
above (M) LTP1 and below (H) LTP2. Intervals were set
at the Pmax from the incremental exercise test for 20 sec-
onds. For L, recovery duration (trec) was 120 seconds
(work to rest ratio 1:6); for M, trec was 60 seconds (work
to rest ratio 1:3); and for H, trec was 20 seconds (work to
rest ratio 1:1). All exercises were performed for 30 mi-
nutes at the target workload at the same time of day,
and each exercise session was separated by 1 week. The
continuous and interval exercises were matched for total
duration and mean workload [4]. Short-acting insulin
dose was reduced by 40% for the incremental exercise
test, 25% for L, 50% for M, and 75% for H, 4 hours be-
fore the start of each exercise session. Additional details
about this study were presented previously [4].
Measurements
Blood glucose and blood lactate concentrations were
determined by taking capillary blood samples from
the earlobe at all tests while the patient was at rest
and during warmup, exercise, and recovery. Capillary
blood samples were analyzed by means of an enzym-
atic method with amperometric monitoring (Biosen
S-line®; EKF Diagnostics, Barleben, Germany). Gas ex-
change data were collected continuously during all
tests, and 5-second average data were used for
analyses (ZAN 600; nSpire Health, Oberthulba,
Germany). The patient’s heart rate was measured
beat-to-beat during all tests, and 5-second average
data were used for calculations (PE 4000; Polar
Electro Finland Oy, Kempele, Finland). Adrenaline,
noradrenaline, cortisol, insulin-like growth factor 1,
and glucagon levels were measured using blood
samples obtained from the cubital vein before the
start of exercise, after 15 minutes of exercise, and at
the end of each 30 minutes of continuous and inter-
val exercise testing.
Findings
The incremental exercise test resulted in a maximum oxy-
gen uptake of 57 ml kg−1 minute−1 and a Pmax of 300 W.
Absolute values of power output were 86 W at LTP1 and
205 W at LTP2, respectively. Mean exercise intensities
prescribed in relation to LTP1 and LTP2, for both the con-
tinuous and interval exercises, corresponded to 71 W
(24% of Pmax) for L, 101 W (34% of Pmax) for M, and 190
W (63% of Pmax) for H. Short-acting insulin reductions at
the start of the exercises resulted in blood glucose concen-
trations of 11.97 mmol L −1 (L), 15.75 mmol L −1 (M), and
14.43 mmol L −1 (H) for the continuous exercises tests, as
well as 9.82 mmol L −1 (L), 13.87 mmol L −1 (M), and
11.95 mmol L −1 (H) for the interval exercise tests,
respectively. Delta blood glucose levels (difference
between start and end of the exercise) for the continuous
exercise tests were 1.38 mmol L −1 (L), 0.00 mmol L −1
(M) and −0.57 mmol L −1 (H), as well as 0.73 mmol L −1
(L), −0.03 mmol L −1 (M), and 0.65 mmol L −1 (H), for the
interval exercise tests. Normal hormone responses were
found, as displayed in Fig. 1. Furthermore, normal
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responses in lactate, respiratory data, and heart rate were
observed, as shown in Table 1.
Discussion
As stated by Shetty et al. [1], blood glucose generally
drops during low- and moderate-intensity exercise in
people with type 1 diabetes, but it may even increase dur-
ing and after high-intensity exercise [7]. Adrenaline and
noradrenaline have been shown to be the main regulators
to target for avoiding blood glucose decreases during
high-intensity exercise due to increased rates of glyco-
gen breakdown. Contrarily, our laboratory previously
Fig. 1 Adrenaline, glucose, noradrenaline, cortisol, glucagon, and insulin-like growth factor 1 responses for the three different exercise intensities
(solid line = low workload, dashed line = moderate workload, dashed-dotted line = heavy workload) for continuous exercise and high-intensity
interval exercise in a single patient with type 1 diabetes exhibiting an atypical blood glucose time course during exercise. Accompanying blood
glucose levels for continuous exercise and high-intensity interval exercise are given for adrenaline responses in the first segment (solid line = low
workload, dashed line = moderate workload, dashed-dotted line = heavy workload). CE Continuous exercise, HIIE High-intensity interval exercise
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found a decrease in blood glucose concentration in
all intensity domains of continuous and high-intensity
interval exercise, which was found to be significantly
related to exercise intensity [8].
Paradoxically, in our patient, during neither low- nor
moderate- or high-intensity exercise did blood glucose
decrease as expected, independently of the mode of ex-
ercise applied, despite other markers being found to be
within normal limits. Although the patient’s catechol-
amine levels were comparable to the whole group inves-
tigated [4] and did not reveal exaggerated counteraction,
no changes in blood glucose concentrations were ob-
served. At first sight, no plausible causes for such a para-
doxical response can be suggested, because the person
injected his regular basal insulin dose, did not ingest
supplemental carbohydrates, and did not have any
known history of insulin insensitivity.
One hypothetical explanation might be impaired glu-
cose transporter type 4 (GLUT-4) translocation during
exercise. Especially during low-intensity exercise, a sig-
nificant increase in myosin heavy chain, type I, has been
reported [9], which enhances muscular glucose uptake,
accompanied by a decrease in blood glucose concentra-
tion in type 1 diabetes. Even so, a detailed mechanism of
GLUT-4 response to muscle contraction is not yet fully
understood, but it is assumed that upstream signaling
pathways that lead to GLUT-4 translocation include 5′-
adenosine monophosphate-activated protein kinase, Ca2
+/calmodulin-dependent protein kinase II, and nitric
oxide synthase [9]. If one of these signaling molecules is
inhibited, this could influence the blood glucose
response during physical activity and exercise.
To the best of our knowledge, this is the first report of
no blood glucose decrease during different types of exer-
cise with varying exercise intensities and modes in a
man with long-lasting type 1 diabetes, despite
physiologically normal hormone responses were found.
Exaggerated insulin dose reductions can cause hypergly-
cemia and may lead to development of ketosis during
physical activity. Especially in people with type 1 dia-
betes who are performing high-intensity exercises on a
regular basis (for example, sport games, interval training,
competitive sports), stable or increasing blood glucose
responses during exercise might raise the risk of life-
threatening ketosis.
Conclusions
For our patient, who did not respond even to low-
and moderate-intensity exercise, we discouraged pre-
exercise insulin dose reductions to avoid severe
hyperglycemia and to minimize any negative impact
of regular periexercise hyperglycemia on long-term
glycemic control. From a clinical point of view, the
finding in our study highlights the need to perform
different types of exercise tests (incremental exercise
test, continuous and interval exercises) in physically
active people with type 1 diabetes. Depending on in-
dividual sports, this should be performed to avoid
drastic hyperglycemic blood glucose excursions
because there might be glucose nonresponders to
low- and moderate-intensity exercise.
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Table 1 Lactate, respiratory exchange ratio, and heart rate responses
during continuous exercise and high-intensity interval exercise of low,
moderate, and high intensities
Low
intensity
Moderate
intensity
High
intensity
Lactate
CE, mmol L−1 0.59 ± 0.11 1.32 ± 0.19 4.52 ± 0.70
HIIE, mmol L−1 1.44 ± 0.45 2.57 ± 0.55 5.11 ± 1.37
RER
CE 0.81 ± 0.03 0.88 ± 0.03 0.91 ± 0.03
HIIE 0.93 ± 0.08 0.94 ± 0.07 0.95 ± 0.04
Heart rate
CE, beats minute−1 99 ± 3 111 ± 5 164 ± 8
HIIE, beats minute−1 93 ± 16 118 ± 12 165 ± 11
Abbreviations: CE Continuous exercise, HIIE High-intensity interval exercise, RER
Respiratory exchange ratio
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